Consequently, the high expression of E2F1 and E2F2, alongside RB1 inactivation and activation of downstream oncogenes, constitutes a complex regulatory network that significantly influences the onset, progression, and prognosis of lung cancer, particularly NSCLC. This evidence concerns the gene E2F2 and non-small cell lung carcinoma.